Old Web
English
Sign In
Acemap
>
Paper
>
BASILIXIMAB (SIMULECT®) REDUCES THE RATE AND SEVERITY OF ACUTE REJECTION IN ADULT LIVER TRANSPLANT RECIPIENTS.: Abstract# 26
BASILIXIMAB (SIMULECT®) REDUCES THE RATE AND SEVERITY OF ACUTE REJECTION IN ADULT LIVER TRANSPLANT RECIPIENTS.: Abstract# 26
2000
Peter Neuhaus
Bjoern Nashan
Pierre-Alain Clavien
Dilip S. Kittur
Mauro Salizzoni
Antoni Rimola
Kamal Abeywickrama
Christine-Elke Ortmann
Lawrence Chodoff
Michael Hall
Alexander Korn
Keywords:
Diabetes mellitus
Basiliximab
Medicine
Immunology
Internal medicine
adult liver
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
8
Citations
NaN
KQI
[]